Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro-Reference-Cited by-同舟云学术

Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro

Published:2016-03-01 Issue:4 Volume:13 Page:1405-1412
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Brachet Guillaume¹,Respaud Renaud²,Arnoult Christophe³,Henriquet Corinne⁴,Dhommée Christine³,Viaud-Massuard Marie-Claude⁵,Heuze-Vourc’h Nathalie⁶,Joubert Nicolas⁵,Pugnière Martine⁴,Gouilleux-Gruart Valérie¹

Affiliation:

1. CNRS, GICC UMR 7292, CHRU de Tours, Service d’Immunologie, Université François Rabelais de Tours, Tours, France

2. CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacie, Université François-Rabelais de Tours, Tours, France

3. CNRS, GICC UMR 7292, Université François Rabelais de Tours, Tours, France

4. IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Université Montpellier, ICM Institut Régional du Cancer, Montpellier, F-34090 France

5. CNRS, GICC UMR 7292, Université François Rabelais de Tours, Tours, France

6. INSERM U1100, Université François Rabelais de Tours, Tours, France

Funder

Agence Nationale de la Recherche

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00082

Reference39 articles.

1. Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma